Literature DB >> 29129008

High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.

Christina Charles-Schoeman1, David Meriwether2, Yuen Yin Lee2, Ani Shahbazian2, Srinivasa T Reddy2.   

Abstract

The objective of this study was to evaluate oxidation products of arachidonic acid and linoleic acid in lipoproteins and synovial fluid (SF) from patients with active rheumatoid arthritis (RA) compared to non-RA controls. High-density lipoproteins (HDL) and low-density lipoproteins (LDL) were isolated from plasma using fast protein liquid chromatography and HDL was isolated from SF using dextran sulfate precipitation. 5-Hydroxyeicosatetraenoic acid (HETE), 12-HETE, 15-HETE, 9 hydroxyoctadecadienoic (HODE), and 13-HODE levels were measured in HDL, LDL, and SF by liquid chromatography-tandem mass spectrometry. HDL's anti-inflammatory function, cholesterol levels, myeloperoxidase (MPO) and paraoxonase 1 (PON1) activities were determined as previously. 5-HETE, 15-HETE, 9-HODE, and 13-HODE levels were significantly increased in HDL and LDL from patients with active RA (n = 10) compared to healthy controls (n = 8) and correlated significantly with measures of systemic inflammation, particularly in HDL (r = 0.65-0.80, p values < 0.004). Higher HETES and HODES in HDL were also significantly correlated with impaired HDL function as measured by the HDL inflammatory index (HII) (r = 0.54-0.58; p values < 0.03). 15-HETE levels and MPO activity were higher in RA SF (n = 10) compared to osteoarthritis (OA) SF(n = 11), and HDL from RA SF had worse function compared to OA SF HDL (HII = 2.1 ± 1.9 and 0.5 ± 0.1), respectively (p < 0.05). Oxidation products of arachidonic acid and linoleic acid are increased in HDL and LDL from patients with active RA compared to healthy controls, and are associated with worse anti-oxidant function of HDL. These results suggest a potential mechanism by which oxidative stress from active RA increases oxidized fatty acids in HDL, promoting HDL dysfunction, and thereby increasing atherosclerotic risk.

Entities:  

Keywords:  Fatty acids; High density lipoprotein; Low density lipoprotein; Rheumatoid arthritis

Mesh:

Substances:

Year:  2017        PMID: 29129008      PMCID: PMC6148336          DOI: 10.1007/s10067-017-3896-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  42 in total

Review 1.  Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity.

Authors:  Maarten Boers; Ben Dijkmans; Sherine Gabriel; Hilal Maradit-Kremers; James O'Dell; Theodore Pincus
Journal:  Arthritis Rheum       Date:  2004-06

2.  L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.

Authors:  Satoshi Imaizumi; Victor Grijalva; Mohamad Navab; Brian J Van Lenten; Alan C Wagner; G M Anantharamiah; Alan M Fogelman; Srinivasa T Reddy
Journal:  Drug Metab Lett       Date:  2010-08

3.  Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

Authors:  Christina Charles-Schoeman; Yuen Yin Lee; Victor Grijalva; Sogol Amjadi; John FitzGerald; Veena K Ranganath; Mihaela Taylor; Maureen McMahon; Harold E Paulus; Srinivasa T Reddy
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

4.  Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients.

Authors:  W Jira; G Spiteller; W Carson; A Schramm
Journal:  Chem Phys Lipids       Date:  1998-01       Impact factor: 3.329

Review 5.  Cardiovascular comorbidity in rheumatic diseases.

Authors:  Michael T Nurmohamed; Maaike Heslinga; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

6.  High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals.

Authors:  Anna Scanu; Francesca Oliviero; Lyssia Gruaz; Paolo Sfriso; Assunta Pozzuoli; Federica Frezzato; Carlo Agostini; Danielle Burger; Leonardo Punzi
Journal:  Arthritis Res Ther       Date:  2010-02-11       Impact factor: 5.156

7.  Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis.

Authors:  F Oliviero; P Sfriso; G Baldo; J-M Dayer; S Giunco; A Scanu; D Bernardi; R Ramonda; M Plebani; L Punzi
Journal:  Clin Exp Rheumatol       Date:  2009 Jan-Feb       Impact factor: 4.473

8.  HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease.

Authors:  C Morgantini; D Meriwether; S Baldi; E Venturi; S Pinnola; A C Wagner; A M Fogelman; E Ferrannini; A Natali; S T Reddy
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-01-22       Impact factor: 4.222

9.  Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes.

Authors:  Cecilia Morgantini; Andrea Natali; Beatrice Boldrini; Satoshi Imaizumi; Mohamad Navab; Alan M Fogelman; Ele Ferrannini; Srinivasa T Reddy
Journal:  Diabetes       Date:  2011-08-18       Impact factor: 9.461

Review 10.  Oxidation in rheumatoid arthritis.

Authors:  Carol A Hitchon; Hani S El-Gabalawy
Journal:  Arthritis Res Ther       Date:  2004-10-13       Impact factor: 5.156

View more
  12 in total

1.  Association between activity and genotypes of paraoxonase1 L55M (rs854560) increases the disease activity of rheumatoid arthritis through oxidative stress.

Authors:  Maryam Tanhapour; Shiva Shahmohamadnejad; Asad Vaisi-Raygani; Amir Kiani; Yadola Shakiba; Zohreh Rahimi; Fariborz Bahrehmand; Ebrahim Shakiba; Ali-Akbar Vaisi-Raygani; Reza Alibakhshi; Atefeh Eivazi; Tayebeh Pourmotabbed
Journal:  Mol Biol Rep       Date:  2018-12-01       Impact factor: 2.316

2.  Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis.

Authors:  Amir A Razmjou; Jennifer M Wang; Ani Shahbazian; Srinivasa Reddy; Christina Charles-Schoeman
Journal:  Clin Rheumatol       Date:  2022-09-22       Impact factor: 3.650

3.  High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies.

Authors:  Sangmae Sharon Bae; Yuen Yin Lee; Ani Shahbazian; Jennifer Wang; David Meriwether; Ilana Golub; Buzand Oganesian; Tyler Dowd; Srinivasa T Reddy; Christina Charles-Schoeman
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.580

4.  The impact of aerobic and isometric exercise on different measures of dysfunctional high-density lipoprotein in patients with hypertension.

Authors:  Nikolaos Pagonas; Stergios Vlatsas; Frederic Bauer; Felix S Seibert; B Sasko; I Buschmann; O Ritter; Theodoros Kelesidis; Timm H Westhoff
Journal:  Eur J Prev Cardiol       Date:  2019-05-08       Impact factor: 7.804

5.  Integrated Serum and Fecal Metabolomics Study of Collagen-Induced Arthritis Rats and the Therapeutic Effects of the Zushima Tablet.

Authors:  Jinjun Shan; Linxiu Peng; Wenjuan Qian; Tong Xie; An Kang; Bei Gao; Liuqing Di
Journal:  Front Pharmacol       Date:  2018-08-14       Impact factor: 5.810

6.  Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice.

Authors:  Christina Charles-Schoeman; Jennifer Wang; Ani Shahbazian; Yuen Yin Lee; Xiaoyan Wang; Victor Grijalva; Ernest Brahn; Diana M Shih; Asokan Devarajan; Christy Montano; Aldons J Lusis; Srinivasa T Reddy
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

Review 7.  Insights in the Role of Lipids, Oxidative Stress and Inflammation in Rheumatoid Arthritis Unveiled by New Trends in Lipidomic Investigations.

Authors:  Helena Beatriz Ferreira; Tânia Melo; Artur Paiva; Maria do Rosário Domingues
Journal:  Antioxidants (Basel)       Date:  2021-01-02

Review 8.  HDL and persistent inflammation immunosuppression and catabolism syndrome.

Authors:  Grant Barker; Julia R Winer; Faheem W Guirgis; Srinivasa Reddy
Journal:  Curr Opin Lipidol       Date:  2021-10-01       Impact factor: 4.616

Review 9.  The Effects of Linoleic Acid Consumption on Lipid Risk Markers for Cardiovascular Disease in Healthy Individuals: A Review of Human Intervention Trials.

Authors:  Erik Froyen; Bonny Burns-Whitmore
Journal:  Nutrients       Date:  2020-08-04       Impact factor: 5.717

Review 10.  High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.

Authors:  Maria Pia Adorni; Nicoletta Ronda; Franco Bernini; Francesca Zimetti
Journal:  Cells       Date:  2021-03-05       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.